Showing results (161-170 of 174) with videos related to
Sort By:
Pageof 18
Sexually Transmitted Infections|October 24, 2003
Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya Region, TanzaniaG Riedner, M Rusizoka, O Hoffmann, et al.British Journal of Cancer|February 23, 1999
Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo resultsM Raderer, G Hamilton, A Kurtaran, et al.Psychotherapie, Psychosomatik, Medizinische Psychologie|September 1, 1996
[Operationalized Psychodynamic Diagnosis in a trial--results of multicenter acceptability and practicability study]H J Freyberger, B Dierse, W Schneider, et al.Paediatric Anaesthesia|August 19, 2010
Insufflation vs intubation during esophagogastroduodenoscopy in childrenClifford O Hoffmann, Paul J Samuels, Eileen Beckman, et al.Pharmacogenetics and Genomics|February 14, 2009
Bioinformatic and functional analysis of TGFBR1 polymorphismsMarkus A Schirmer, Arne O Hoffmann, Radu Campean, et al.Journal of Virology|September 6, 2005
In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfectionF E McCutchan, M Hoelscher, S Tovanabutra, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2023
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trialN Harbeck, P A Fasching, R Wuerstlein, et al.ESMO Open|November 10, 2022
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)M Schmidt, K Lübbe, T Decker, et al.ESMO Open|November 28, 2021
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study programV Müller, M Banys-Paluchowski, T W P Friedl, et al.International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivityMarkus A Schirmer, Jürgen Brockmöller, Margret Rave-Fränk, et al.Pageof 18